South San Francisco, CA, United States of America

Kenneth S Lin


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 46(Granted Patents)


Location History:

  • Los Altos, CA (US) (2017)
  • South San Francisco, CA (US) (2020 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Kenneth S. Lin from South San Francisco, CA

Introduction

Kenneth S. Lin is a prominent inventor based in South San Francisco, CA, who has made significant contributions to the field of biotechnology through his innovative work. With three patents to his name, he stands out for his advancements in immunotherapy and the treatment of various medical conditions.

Latest Patents

Kenneth's latest patents include breakthrough inventions related to SIRP-gamma polypeptide compositions aimed at treating cancer and other serious health issues. These patents detail the use of SIRP-gamma, SIRP-beta, or SIRP-beta2 decoy polypeptides for effective immunotherapy. The inventions target the treatment of a diverse range of conditions such as cancer, anemia, transplant-related issues, asthma, allergy, autoimmune diseases, and viral infections.

Career Highlights

Kenneth is currently associated with Ab Initio Biotherapeutics, Inc., where his expertise in biotherapeutics plays a vital role in the company’s innovative approaches to healthcare. His groundbreaking research and development in polypeptide compositions underscore his commitment to transforming treatment modalities in the biotechnology sector.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues, including Aaron Michael Ring and Roy Louis Maute. Together, they have worked to refine and expand the applications of Kenneth's remarkable inventions, fostering a spirit of innovation and discovery within their field.

Conclusion

Kenneth S. Lin's impactful work continues to pave the way for new therapeutic avenues in medicine. His dedication to advancing biotherapeutics reflects a profound commitment to improving health outcomes and exemplifies the spirit of innovation in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…